C-Reactive Protein Elevation and the Risk of Colorectal Cancer

Gastroenterology Nursing

Volumn 27, Issue 5, 2004, Pages 246-247

  Saddler, Delores ^a   Greenwald, Beverly ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TUMOR MARKER;

BLOOD; COLORECTAL TUMOR; HUMAN; INFLAMMATION; MASS SCREENING; METABOLISM; METHODOLOGY; PREDICTION AND FORECASTING; REPRODUCIBILITY; REVIEW; RISK FACTOR; STANDARD;

C-REACTIVE PROTEIN; COLORECTAL NEOPLASMS; HUMANS; INFLAMMATION; MASS SCREENING; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 16544387721     PISSN: 1042895X     EISSN: 15389766     Source Type: Journal    
DOI: 10.1097/00001610-200409000-00010     Document Type: Review

References (11)

1. Agency for Health Care Policy and Research. (2003). Retrieved December 30, 2003, from http://www.apcpr.gov/clinic/colorsum.htm
2. American Cancer Society (2003). Retrieved July 31, 2003, from http://www.cancer.org/docroot/CRI/content/CRI_2_4_3X_Can_colon_and_rectum_cancer_be_found_early.asp?sitearea=CRI
3. Baron, J. A. Cole, B. F., Sandler, R. S., Haile, R. W., Ahnen, D., Bresalier, R., McKeown-Eyssen, G., Summers, R. W., Rothstein, R., Burke, C. A., Snover, D. C., Church, T. R., Allen, J. I., Beach, M., Beck, G. J., Bond, J. H., Byers, T., Greenberg, E. R., Mandel, J. S., Marcon, N., Mott, L. A., Pearson, L., Saibil, F., & van Stolk, R. U. (2003). A randomized trial of aspirin to prevent colorectal adenomas. New England Journal of Medicine, 348 (10), 891-899.
4. Erlinger, T. P., Platz, E. A., Rifai, N., & Helzlsouer, K. J. (2004). C-reactive protein and the risk of incident colorectal cancer. Journal of the American Medical Association, 291 (5), 585-590.
5. Gann, P. H. Manson, J. E., Glynn, R. J., Buring, J. E., & Hennekens, C. H. (1993). Low-dose aspirin and incidence of colorectal tumors in a randomized trial. Journal of the National Cancer Institute, 85 (15), 1220-1224.
6. Greenberg, E. R., Baron, J. A., Freeman, D. H., Mandel, J. S., & Haile, R. (1993). Reduced risk of large-bowel adenomas among aspirin users: The Polyp Prevention Study Group. Journal of the National Cancer Institute, 85, (11), 912-916.
7. Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J., & Thun, M. (2004). Cancer statistics 2004. CA: A Cancer Journal for Clinicians, 54 (1), 8-29.
8. National Institute of Health. (2002). Retrieved April 14, 2004, from http://www.nlm.nih.gov/medlineplus/ency/article/003356.htm
9. Pasch, B., & Serhan, C. N. (2004). Is C-reative protein an inflammation opsonin that signals colon cancer risk?Journal of the American Medical Association, 291 (5), 623-624.
10. Sandler, R. S., Galanko, J. C., Murray, S. C., Helm, J. F., & Woosley, J. T. (1998). Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas. Gastroenterology, 114 (3), 441-447.
11. Sandler, R. S., Halabi, S., Baron, J. A., Budinger, S., Paskett, E., Keresztes, R., Petrelli, N., Pipas, J. M., Karp, D. D., Loprinzi, C. L., Steinbach, G., & Schilski, R. (2003). A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. New England Journal of Medicine, 348 (10), 883-890.